Article Information
History
- February 11, 2022.
Article Versions
- Version 1 (January 8, 2021 - 05:39).
- Version 2 (March 15, 2021 - 01:24).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand
- 2Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, New Richards Building, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LG, UK
- 3Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA
- ↵*jwatowatson{at}gmail.com
Posted February 11, 2022.
Characterising SARS-CoV-2 viral clearance kinetics to improve the design of antiviral pharmacometric studies
